Opportunities & Announcements

All NIAID-relevant grant funding opportunity announcements are listed here. Any amendments to an announcement will be listed in the funding opportunity announcement. For contracts, see NIAID Contract Solicitations. For other funding opportunity resources, see Find a Foundation or Other Funding Source.

Showing results filtered by:
Title Activity Code Posting Date Expiration Date
HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01)- PA-17-291 R01 May 17, 2017 May 8, 2018
HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R21)- PA-17-292 R21 May 17, 2017 May 8, 2018
HIV-1 Infection of the Central Nervous System (R01)- PA-17-100 R01 January 5, 2017 January 8, 2020
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)- PAR-18-319 P01 October 13, 2017 March 14, 2020
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)- PA-17-279 R01 May 12, 2017 May 8, 2020
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)- PA-17-278 R21 May 12, 2017 May 8, 2020
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21)- PA-15-106 R21 January 29, 2015 January 8, 2018
Role of Exosomes in HIV Pathogenesis- PA-15-107 R21 January 30, 2015 January 8, 2018
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01)- PA-15-105 R01 January 29, 2015 January 8, 2018
Characterization of Mycobacterial Induced Immunity in HIV-Infected and Uninfected Individuals- PAR-15-360 R21 December 11, 2015 January 12, 2018
Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects- PAR-16-117 R01 March 3, 2016 January 24, 2018
Understanding Immunopathogenesis of Tuberculosis in HIV-1 Infected and Exposed Children (R01 Clinical Trial Not Allowed)- RFA-AI-17-039 R01 December 4, 2017 March 15, 2018
Harnessing Big Data to Halt HIV- PA-15-273 R01 June 5, 2016 May 8, 2018
Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation- PA-15-268 R34 May 28, 2016 May 8, 2018
Exploiting RNA as a Target for HIV Interventions- PA-15-272 R21 June 5, 2015 May 8, 2018
Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01 Clinical Trial Optional)- PAR-18-254 R01 November 29, 2017 May 9, 2018
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP)- PAR-16-262 R01 May 17, 2016 January 5, 2019
Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir- PAR-16-115 R01 February 25, 2016 January 10, 2019
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design- PAR-16-254 R01 May 11, 2016 January 12, 2019
Phylodynamic Tracking of HIV Transmission (R01)- PAR-17-048 R01 November 4, 2016 March 16, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R43/R44)- PA-16-184 R43/R44 April 12, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R43/R44)- PA-16-207 R43/R44 April 19, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R41/R42)- PA-16-208 R41/R42 April 19, 2016 April 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R41/R42)- PA-16-182 R41/R42 April 12, 2016 April 6, 2019
Innovation for HIV Vaccine Discovery (R01)- PAR-17-263 R01 April 25, 2017 August 2, 2019
Detection of HIV for Self-Testing (R61/R33)- PAR-17-471 R61/R33 August 25, 2017 December 7, 2019
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)- PA-17-113 R01 January 9, 2017 January 8, 2020
Eradication of HIV-1 From Central Nervous System Reservoirs (R01)- PA-17-084 R01 December 13, 2016 January 8, 2020
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)- PA-17-114 R01 January 9, 2017 January 8, 2020
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)- PAR-18-411 R01 November 16, 2017 March 14, 2020
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)- PA-17-306 R21 June 7, 2017 May 8, 2020
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)- PA-17-280 R01 May 12, 2017 May 8, 2020
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)- PA-17-281 R21 May 12, 2017 May 8, 2020
Imaging the Persistent HIV Reservoir (R01)- PA-17-305 R01 June 6, 2017 May 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)- PA-17-282 R21 May 12, 2017 September 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)- PA-17-283 R01 May 12, 2017 September 8, 2020